More than a Mite Contagious: Crusted Scabies - 23/08/17
Doi : 10.1016/j.amjmed.2017.05.007
Jessica Seidelman, MD a, Reed M. Garza, MD b, Colin M. Smith, MD c, d, Vance G. Fowler, MD, MHS a, e, ⁎ 
a Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, NC
b Department of Dermatology, Duke University School of Medicine, Durham, NC
c Division of Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC
d Department of Psychiatry, Duke University School of Medicine, Durham, NC
e Duke Clinical Research Institute, Duke University, Durham, NC
∗Requests for reprints should be addressed to Vance G. Fowler, Jr, MD, MHS, Division of Infectious Diseases and International Health, PO Box 102359, Durham, NC 27710.Division of Infectious Diseases and International HealthPO Box 102359DurhamNC27710
Thomas J. Marrie, MD, Section Editor
Le texte complet de cet article est disponible en PDF.Plan
| Funding: This work was supported by Grants K24-AI093969 (VGF) from the National Institutes of Health. |
|
| Conflict of Interest: VGF served as Chair of V710 Scientific Advisory Committee (Merck); has received grant support from Cerexa/Actavis, Pfizer, Advanced Liquid Logics, National Institutes of Health, MedImmune, Cubist/Merck, Karius, Contrafect, and Genentech; has National Institutes of Health Small Business Technology Transfer/Small Business Innovation Research grants pending: Affinergy, Locus, Medical Surface, Inc; has been a paid consultant for Achaogen, Astellas, Arsanis, Affinergy, Basilea, Bayer, Cerexa, Contrafect, Cubist, Debiopharm, Durata, Grifols, Genentech, MedImmune, Merck, Medicines Co, Pfizer, Novartis, Novadigm, Theravance, and xBiotech; has received honoraria from Theravance and Green Cross; and has a patent pending in sepsis diagnostics. |
|
| Authorship: All authors had access to the data and played a role in writing this manuscript. The opinions expressed in this article are the authors' own and do not necessarily reflect the views of the Indian Health Service, the Department of Health and Human Services, or the US Government. |
© 2017
Elsevier Inc. Tous droits réservés.
Vol 130 - N° 9
P. 1042-1044 - septembre 2017 Retour au numéro
Article précédent
- Improving Value by Reducing Unnecessary Telemetry and Urinary Catheter Utilization in Hospitalized Patients
- Charlie M. Wray, John Fahrenbach, Nikhil Bassi, Poushali Bhattacharjee, Matthew Modes, Michael D. Howell, Vineet M. Arora
- Smoke and Mirrors: Moyamoya Syndrome
- Kathryn B. Wunderle, Caroline McCulley
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?